Respiratory omics for early detection of COPD-to-lung cancer transition: mechanisms, biomarkers and clinical translation.

Authors

Chengyang Liu, Wenhui Jia, Siyuan Jing, Chunling Dong

Published in

Frontiers in cell and developmental biology. Volume 14. Pages 1957266. Epub Sep 08, 2026.

Abstract

Chronic obstructive pulmonary disease (COPD) substantially increases the risk of lung cancer, yet biomarkers capable of identifying malignant transition before radiological abnormalities become evident remain lacking. Respiratory omics has emerged as a promising non-invasive approach for monitoring dynamic molecular alterations during disease progression through the analysis of exhaled volatile organic compounds (VOCs) and exhaled breath condensate (EBC). This review summarizes current evidence on respiratory biomarkers associated with COPD-to-lung cancer transition, emphasizing the biological mechanisms underlying their dynamic evolution and their potential applications in early detection and risk stratification. Rather than considering COPD and lung cancer as separate diseases, we discuss respiratory biomarker changes across the disease continuum and highlight their translational value for identifying high-risk individuals. Finally, we outline the major challenges limiting clinical implementation, including biomarker standardization and prospective validation, and discuss future directions involving multi-omics integration, artificial intelligence, and precision surveillance. Respiratory omics has the potential to advance non-invasive risk assessment and facilitate earlier intervention for COPD-associated lung cancer.

PMID:
42774579
Bibliographic data and abstract were imported from PubMed on 18 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.